{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T11:24:26Z","timestamp":1768303466242,"version":"3.49.0"},"reference-count":68,"publisher":"Media Sphere Publishing House","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>The literature sources devoted to the problem of the formation of neuropathic pain in lumbosacral dorsalgia and the effective treatment regimens used are analyzed. The clinical and pathogenetic justification of the appointment of complex drug treatment is presented, taking into account the most significant causes of acute and chronic nonspecific back pain \u2014 radicular, facet, musculotonic syndromes. It has been shown that the most effective drugs are antiepileptic drugs, nonsteroidal anti-inflammatory drugs, muscle relaxants of central prologued action. It has been shown that the intensity of neuropathic pain decreases with the administration of pregabalin. In acute nonspecific back pain, the use of aceclofenac is effective. The severity of musculotonic pain syndrome is significantly reduced when using tolperizone (Midocalm-long). The results of the analyzed studies confirm the effectiveness and safety of the combination.<\/jats:p>","DOI":"10.17116\/jnevro2024124111152","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:56:57Z","timestamp":1734501417000},"page":"152","source":"Crossref","is-referenced-by-count":1,"title":["Control of neuropathic pain in lumbosacral dorsalgia"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2578-5783","authenticated-orcid":false,"given":"V.V.","family":"Andreev","sequence":"first","affiliation":[{"name":"Academian I.P. Pavlov First Saint Petersburg State Medical University","place":["St. Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2024124111152-1","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2021-3-107-112"},{"key":"key-10.17116\/jnevro2024124111152-2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51788"},{"key":"key-10.17116\/jnevro2024124111152-3","unstructured":"Andersson GB. The epidemiology of spinal disorders. In: Frymoyer JW, editor. The adult spine: principles and practice. 2nd ed. New York: Raven Press, 1997;93-141"},{"key":"key-10.17116\/jnevro2024124111152-4","doi-asserted-by":"crossref","unstructured":"Jordan KP, Kadam UT, Hayward R, et al. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010;11:144","DOI":"10.1186\/1471-2474-11-144"},{"key":"key-10.17116\/jnevro2024124111152-5","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-06178-3"},{"key":"key-10.17116\/jnevro2024124111152-6","unstructured":"Shostak NA, Nasonova VA, Shemetov DA, et al. Pain in the lower back as a multidisciplinary problem. Therapeutic Archive. 2000;10:57-60. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-7","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2023-0035"},{"key":"key-10.17116\/jnevro2024124111152-8","unstructured":"Danilov AB. Types and pathophysiological mechanisms of pain \u2014 significance for clinical practice. Manage Pain. 2014;1:4. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-9","unstructured":"Podchufarova EV, Yakhno NN. Back pain. M.: GEOTAR-Media, 2009. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-10","doi-asserted-by":"crossref","unstructured":"Bruggemann G, Koehler CO, Koch EM. Results of a double\u2014 blind study of diclofenac+vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study. Klin Wochenschr. 1990;19:116-120","DOI":"10.1007\/BF01646858"},{"key":"key-10.17116\/jnevro2024124111152-11","unstructured":"Khabirov FA. Guidelines for clinical neurology of the spine. Kazan: Medicine, 2006. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-12","doi-asserted-by":"crossref","unstructured":"Davis R. A Long-term outcome analysis of 984 surgically treated herniated lumbar discs. J Neurosurg. 1994;80(3):415-421","DOI":"10.3171\/jns.1994.80.3.0415"},{"key":"key-10.17116\/jnevro2024124111152-13","unstructured":"Vane AM, Avrutsky MYa. Pain and anesthesia. M.: Medicine, 1997. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-14","unstructured":"Yumashev GS, Furman ME. Osteochondrosis of the spine. 2nd ed. M.: Medicine, 1984. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-15","doi-asserted-by":"crossref","unstructured":"Murata Y. Local application of interleikin-6 to the dorsal root ganglion induces tumor necrosis factor in the dorsal root ganglion cells. Spine. 2011;36:926-932","DOI":"10.1097\/BRS.0b013e3181e7f4a9"},{"key":"key-10.17116\/jnevro2024124111152-16","unstructured":"Podchufarova EV. Pain in the lumbosacral region: diagnosis and treatment. RMJ. 2004;10:581-584. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-17","doi-asserted-by":"crossref","unstructured":"Lewis P, Weir B, Broad R, et al. Long-term prospective study of lumbosacral discectomy. J Neurosurg. 1987;67(1):49-53","DOI":"10.3171\/jns.1987.67.1.0049"},{"key":"key-10.17116\/jnevro2024124111152-18","unstructured":"Pain syndromes in neurological practice. Ed. by A.M. Vane. M.: MEDpress-inform, 2001. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-19","unstructured":"Danilov AB, Davydov OS. Neuropathic pain. Moscow: \u00abBorges\u00bb, 2007. 198 s. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-20","unstructured":"Podchufarova EV. Chronic back pain: pathogenesis, diagnosis, treatment. RMJ. 2003;11(25):32-37. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-21","doi-asserted-by":"crossref","unstructured":"Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low- back pain and its related medical care in the United States. Spine (Phila Pa 1976). 1987;12(3):264-268","DOI":"10.1097\/00007632-198704000-00013"},{"key":"key-10.17116\/jnevro2024124111152-22","doi-asserted-by":"crossref","unstructured":"Manchikanti L, Singh V, Datta S, et al. Comprehensive review of epidemiology, scope, and impact of spinal pain. Spine. 2009;12(4):E35-70","DOI":"10.36076\/ppj.2009\/12\/E35"},{"key":"key-10.17116\/jnevro2024124111152-23","doi-asserted-by":"crossref","unstructured":"Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13(3):185-190","DOI":"10.1007\/s11916-009-0032-y"},{"key":"key-10.17116\/jnevro2024124111152-24","doi-asserted-by":"crossref","unstructured":"Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration. J Bone Joint Surg Am. 2006;88(Suppl. 2):68-71","DOI":"10.2106\/JBJS.E.01282"},{"key":"key-10.17116\/jnevro2024124111152-25","doi-asserted-by":"crossref","unstructured":"Oostdam EM, Duivenvoorden HJ. Description of pain and the degree to which the complaints fit the organic diagnosis of low back pain. Pain. 1984;18(1):71-82","DOI":"10.1016\/0304-3959(84)90127-1"},{"key":"key-10.17116\/jnevro2024124111152-26","unstructured":"Kukushkin ML, Tabeeva GR, Podchufarova EV. Pain syndrome: pathophysiology, clinic, treatment. Clinical recommendations. Ed. acad. RAMS Yakhno N.N. M.: IMA- PRESS; 2011. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-27","unstructured":"Alekseev AV, Arinina EE, Arsenyev AO. Nonspecific pain in the lower back. Clinical recommendations for district therapists and general practitioners. M.: Komplekt-Servis; 2008. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-28","doi-asserted-by":"crossref","unstructured":"Deyo RA. Nonsurgical care of low back pain. Neurosurg Clin N Am. 1991;2(4):851-862","DOI":"10.1016\/S1042-3680(18)30705-8"},{"key":"key-10.17116\/jnevro2024124111152-29","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-006-1071-2"},{"key":"key-10.17116\/jnevro2024124111152-30","unstructured":"Van Tulder MW. Muscle relaxants for non-specific low-back pain (Review). The Cochrane Library. 2008;4:CD 3432786"},{"key":"key-10.17116\/jnevro2024124111152-31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012087"},{"key":"key-10.17116\/jnevro2024124111152-32","doi-asserted-by":"crossref","unstructured":"Hunter TS, Robison C, Gerbino PP. Emerging evidence in NSAID pharmacology: important considerations for product selection. Am J Manag Care. 2015;21(7):139-147","DOI":"10.1002\/9781118643440.ch22"},{"key":"key-10.17116\/jnevro2024124111152-33","unstructured":"Pain (a practical guide for doctors). Edited by Yakhno NN, Kukushkin ML. M.: Publishing House of the Russian Academy of Sciences. 2012. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-34","doi-asserted-by":"crossref","unstructured":"Lee Y. Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheum Rep. 2013;15(1):300","DOI":"10.1007\/s11926-012-0300-4"},{"key":"key-10.17116\/jnevro2024124111152-35","unstructured":"Karateev AE, Yakhno NN, Lazebnik LB, et al. The use of nonsteroidal anti-inflammatory drugs. Clinical recommendations. M.: IMA-PRESS, 2009. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-36","unstructured":"Reginster J, Paul I, Henrotin Y. What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies? Rev Med Liege. 2001;56(7):484-488"},{"key":"key-10.17116\/jnevro2024124111152-37","unstructured":"Nasonova VA. Aceclofenac (Aertal) in rheumatology practice. Therapeutic Archive. 2005;77(5):87-90. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-38","unstructured":"Nasonov EL, Yakhno NN, Karateev AE, et al. General principles of treatment for musculoskeletal pain: Interdisciplinary consensus. Nauchno-Prakticheskaya Revmatologiya. 2016;54(3):247-265. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-39","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0285-8"},{"key":"key-10.17116\/jnevro2024124111152-40","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-015-0028-7"},{"key":"key-10.17116\/jnevro2024124111152-41","doi-asserted-by":"crossref","unstructured":"Van de Laar M, Pergolizzi J, Mellinghoff H, et al. Pain Treatment in Arthritis-Related Pain: Beyond NSAIDs. Open Rheumatol J. 2012;6:320-330","DOI":"10.2174\/1874312901206010320"},{"key":"key-10.17116\/jnevro2024124111152-42","doi-asserted-by":"publisher","DOI":"10.1186\/ar4174"},{"key":"key-10.17116\/jnevro2024124111152-43","doi-asserted-by":"crossref","unstructured":"Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075-2094","DOI":"10.1007\/s00586-010-1502-y"},{"key":"key-10.17116\/jnevro2024124111152-44","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2367"},{"key":"key-10.17116\/jnevro2024124111152-45","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2023-2-114-119"},{"key":"key-10.17116\/jnevro2024124111152-46","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-018-5673-2"},{"key":"key-10.17116\/jnevro2024124111152-47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30480-X"},{"key":"key-10.17116\/jnevro2024124111152-48","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0757-1"},{"key":"key-10.17116\/jnevro2024124111152-49","unstructured":"National Institute for Health and Care Excellence (UK). Low Back Pain and Sciatica in Over 16s: Assessment and Management. London; 2016. Available from:  www.nice.org.uk\/guidance\/ng5"},{"key":"key-10.17116\/jnevro2024124111152-50","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2018-2-4-11"},{"key":"key-10.17116\/jnevro2024124111152-51","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2018118121100"},{"key":"key-10.17116\/jnevro2024124111152-52","unstructured":"Parfenov VA, Bogdanov EI, Laskov VB, et al. A multicenter randomized double-blind study of the efficacy and safety of tolperisone hydrochloride prolonged release 450 mg (MidocalmR Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute nonspecific lower back pain. Nevrologiya, neiropsikhiatriya, psikhosomatika=Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):14-22. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-53","unstructured":"Kukushkin ML. Modern view on mechanism of action of mydocalm. Russian Journal of Pain. 2012;2:15-19. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.03.034"},{"key":"key-10.17116\/jnevro2024124111152-55","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089805"},{"key":"key-10.17116\/jnevro2024124111152-56","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979315"},{"key":"key-10.17116\/jnevro2024124111152-57","doi-asserted-by":"crossref","unstructured":"Girish MB. Tolperisone. J Anaesth Clin Pharmacol. 2010;26(3):363-364","DOI":"10.4103\/0970-9185.74793"},{"key":"key-10.17116\/jnevro2024124111152-58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2008.00044.x"},{"key":"key-10.17116\/jnevro2024124111152-59","unstructured":"Sli\u0301va J. Centra\u0301lni\u0301 myorelaxancia ve sve\u030ctle \u00abevidence based medicine\u00bb. Practicus. 2008;5:27-29"},{"key":"key-10.17116\/jnevro2024124111152-60","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03187-9"},{"key":"key-10.17116\/jnevro2024124111152-61","unstructured":"Avakyan GN, Chukanova EI, Nikonov AA. Application of midocalm for correction of vertebrogenic algesic syndromes. S.S. Korsakov Journal of Neurology and Psychiatry. 2000;100(5):26-31. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-62","unstructured":"Hodinka L. Tolperisone in acute low back pain. A randomized, parallel- group, placebo-controlled, double-blind study (Tolerate). Pain. 2001;RGD:57110\/E.17"},{"key":"key-10.17116\/jnevro2024124111152-63","doi-asserted-by":"crossref","unstructured":"Ono H, Fukuda H, Kudo Y. Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. J Pharmacobiodyn. 1984;7(3):171-176","DOI":"10.1248\/bpb1978.7.171"},{"key":"key-10.17116\/jnevro2024124111152-64","unstructured":"Farkas S, Kocsis P, Bielik N. Comparative characterisation of the centrally acting relaxant RGH:5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro. Neurobiology. 1997;5(1):57-58"},{"key":"key-10.17116\/jnevro2024124111152-65","doi-asserted-by":"crossref","unstructured":"Furuta Y, Yoshikawa A. Reversible adrenergic alpha-receptor blocking action of 2, 48-dimethyl-3-piperidino-propiophenone (tolperisone). Jpn J Pharmacol. 1976;26:543-550","DOI":"10.1254\/jjp.26.543"},{"key":"key-10.17116\/jnevro2024124111152-66","unstructured":"Abranyi I. Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin. Hung Med J. 1988;36(2):56-61"},{"key":"key-10.17116\/jnevro2024124111152-67","unstructured":"Danilov AB, Zharkova TR. Chronic radiculopathy: new possibilities of therapy. Russian Journal of Pain. 2013;3(11):19-22. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124111152-68","doi-asserted-by":"crossref","unstructured":"Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769","DOI":"10.1126\/science.288.5472.1765"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:04:39Z","timestamp":1745384679000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/11\/1199772982024111152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,12,18]]}},"alternative-id":["10.17116\/jnevro2024124111152"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2024124111152","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}